These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8360853)

  • 1. Phase diagram of (R)- and (S)-4-hydroxy-2-pyrrolidone mixtures: a new case of a conglomerate-forming system.
    Di Silvestro G; Palmisano G; Pellegata R
    J Pharm Sci; 1993 Jul; 82(7):758-60. PubMed ID: 8360853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the characterization and crystallization of 4-hydroxy-2-pyrrolidone.
    Wang XJ; Wiehler H; Ching CB
    Chirality; 2004 May; 16(4):220-7. PubMed ID: 15034904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of racemic species of chiral drugs using thermal analysis, thermodynamic calculation, and structural studies.
    Li ZJ; Zell MT; Munson EJ; Grant DJ
    J Pharm Sci; 1999 Mar; 88(3):337-46. PubMed ID: 10052993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers.
    Brandel C; Amharar Y; Rollinger JM; Griesser UJ; Cartigny Y; Petit S; Coquerel G
    Mol Pharm; 2013 Oct; 10(10):3850-61. PubMed ID: 23984951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of grinding and humidification on the transformation of conglomerate to racemic compound in optically active drugs.
    Piyarom S; Yonemochi E; Oguchi T; Yamamoto K
    J Pharm Pharmacol; 1997 Apr; 49(4):384-9. PubMed ID: 9232535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new activity model for Mg-Al biotites determined through an integrated approach.
    Dachs E; Benisek A
    Contrib Mineral Petrol; 2019; 174(9):76. PubMed ID: 31496539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride.
    Wang X; Wang XJ; Ching CB
    Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physico-chemical characterization of a novel tricyclic beta-lactam antibiotic.
    Marini A; Berbenni V; Bruni G; Sinistri C; Maggioni A; Orlandi A; Villa M
    J Pharm Sci; 2000 Feb; 89(2):232-40. PubMed ID: 10688752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binary phase diagram of propranolol hydrochloride and crystallization-based enantioseparation.
    Polenske D; Lorenz H; Seidel-Morgenstern A
    J Pharm Sci; 2010 Apr; 99(4):1762-73. PubMed ID: 19798754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state.
    Duddu SP; Grant DJ
    Pharm Res; 1992 Aug; 9(8):1083-91. PubMed ID: 1409382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of DNA single-stranded order to the thermodynamics of duplex formation.
    Vesnaver G; Breslauer KJ
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3569-73. PubMed ID: 2023903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New aspects of the interaction of cholesterol with dipalmitoylphosphatidylcholine bilayers as revealed by high-sensitivity differential scanning calorimetry.
    McMullen TP; McElhaney RN
    Biochim Biophys Acta; 1995 Mar; 1234(1):90-8. PubMed ID: 7880863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomeric 3-chloromandelic acid system: binary melting point phase diagram, ternary solubility phase diagrams and polymorphism.
    Le Minh T; von Langermann J; Lorenz H; Seidel-Morgenstern A
    J Pharm Sci; 2010 Sep; 99(9):4084-95. PubMed ID: 20575001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of polymorphs and solvates of 3-amino-1-(m-trifluoromethylphenyl)-6-methyl-1H-pyridazin-4-one.
    Chauvet A; Masse J; Ribet JP; Bigg D; Autin JM; Maurel JL; Patoiseau JF; Jaud J
    J Pharm Sci; 1992 Aug; 81(8):836-41. PubMed ID: 1357154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of solid-state nature of 2-chloromandelic acid.
    He Q; Zhu J; Gomaa H; Jennings M; Rohani S
    J Pharm Sci; 2009 May; 98(5):1835-44. PubMed ID: 18837015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physico-chemical characterization and stability study of glassy simvastatin.
    Ambike AA; Mahadik KR; Paradkar A
    Drug Dev Ind Pharm; 2005 Oct; 31(9):895-9. PubMed ID: 16306001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid state characterization of dehydroepiandrosterone.
    Chang LC; Caira MR; Guillory JK
    J Pharm Sci; 1995 Oct; 84(10):1169-79. PubMed ID: 8801330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thermoanalytic determination of the enantiomeric purity of selegiline].
    Ladányi L; Szilágyi I; Hermecz I
    Acta Pharm Hung; 1992 Sep; 62(5):231-6. PubMed ID: 1488907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal behaviour and binary phase diagram of (S)-(+)-4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazinedione) (dexrazoxane), a cardioprotective agent, and of its (R)-(-)-enantiomer.
    Vigevani A; Zampieri M; Pellizzato R
    J Pharm Biomed Anal; 1992 Jan; 10(1):31-6. PubMed ID: 1391080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of butyrophenones related to haloperidol.
    Azibi M; Draguet-Brughmans M; Bouche R
    J Pharm Sci; 1984 Apr; 73(4):512-5. PubMed ID: 6726636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.